T50 - the new treatment target for patients with chronic kidney disease


Pathological calcification is a major problem in many diseases, causes human suffering and shortens human life.

We develop and sell a patented Calcification Blood Test, that makes the risk of calcification measurable for the first time. This adds important diagnostic value and supports the optimization of therapies. Products are currently a scalable test kit and a data analysis software. 

Our long-term aim ist to defeat pathological calcifications, which are a major medical problem especially in kidney patients and aging populations.

We are a Swiss startup-company, founded in August 2013 and are located in Nidau, close to Biel/Bienne, in the Canton of Berne. We work under ISO 13485-certified quality management system.